Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...

Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking ... to anyone who wants insight into how blood sugar affects energy, mood, sleep, and long ...

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, blood glucose or respiration ...

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.

Regular monitoring of blood sugar levels is a vital part of diabetes management. It helps to inform diet, meal schedules, physical activity, and when to take medications such as insulin.

Continuous glucose monitoring is helping diabetics and others do a better job of tracking their blood sugar and taking ...